Recurrent pyuria is associated with shorter progression-free survival in dogs with bladder urothelial carcinoma
American Journal of Veterinary Research · 2026
DOI: 10.2460/ajvr.25.12.0438 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2026. Verfasst von Sung-Ho Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University, Se…. Hauptthemen laut MEDLINE: Dog Diseases, Pyuria, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the association between pyuria and clinical outcomes in dogs.
Methods
Data were collected from 2010 through 2025. Pyuria was defined as ≥ 5 WBCs/hpf in urine sediment. Dogs were stratified according to pyuria frequency (0, 1 to 2, or ≥ 3 episodes) and tumor size (< 3 or ≥ 3 cm). Progression-free survival (PFS) and overall survival were analyzed using Kaplan-Meier curves, log-rank tests, and Cox proportional hazards models.
Results
51 dogs diagnosed with bladder urothelial carcinoma (UC) were included. When stratified by pyuria frequency, dogs with ≥ 3 episodes had a significantly shorter median PFS than dogs without pyuria (175 vs 365 days), whereas dogs with 1 to 2 episodes did not differ significantly from the nonpyuria group. In the multivariable analysis, ≥ 3 pyuria episodes remained a negative prognostic factor for PFS (hazard ratio, 3.57; 95% CI, 1.27 to 10.04) even after accounting for the total number of urinalyses performed. Dogs with pyuria at initial diagnosis had a shorter median overall survival than the nonpyuria group (353 vs 531 days).
Conclusions
Dogs with pyuria at initial diagnosis and frequent pyuria (≥ 3 episodes) during the entire treatment period had shorter PFS than dogs without pyuria. Clinical Relevance This finding parallels observations in human medicine and suggests that pyuria may serve as a clinically useful marker of tumor progression in canine UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
- Haemaru Referral Animal Hospital, Seongnam, Republic of Korea.
ORCID-Profile: Sung-Ho Choi, Jin-Kyung Kim, Se-Hoon Kim, Min-Ok Ryu, Kyoung-Won Seo
Zitieren
APA
Choi, S. H., Kim, J. K., Kim, S. H., Ryu, M. O., & Seo, K. W. (2026). Recurrent pyuria is associated with shorter progression-free survival in dogs with bladder urothelial carcinoma. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.12.0438
Vancouver
Choi SH, Kim JK, Kim SH, Ryu MO, Seo KW. Recurrent pyuria is associated with shorter progression-free survival in dogs with bladder urothelial carcinoma. American Journal of Veterinary Research. 2026. doi:10.2460/ajvr.25.12.0438
BibTeX
@article{Choi2026,
author = {Choi, Sung-Ho and Kim, Jin-Kyung and Kim, Se-Hoon and Ryu, Min-Ok and Seo, Kyoung-Won},
title = {Recurrent pyuria is associated with shorter progression-free survival in dogs with bladder urothelial carcinoma},
journal = {American Journal of Veterinary Research},
year = {2026},
doi = {10.2460/ajvr.25.12.0438}
}
EUVIMED